BioMarin Pharmaceutical, Inc. (BMRN)
52.49
-0.39
(-0.74%)
USD |
NASDAQ |
May 27, 15:52
BioMarin Pharmaceutical Free Cash Flow : 759.12M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Ionis Pharmaceuticals, Inc. | -977.73M |
| Alnylam Pharmaceuticals, Inc. | 641.34M |
| BridgeBio Pharma, Inc. | -452.02M |
| Mirum Pharmaceuticals, Inc. | -182.55M |
| Cytokinetics, Inc. | -548.92M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 220.65M |
| Cash from Investing (Quarterly) | 725.53M |
| Cash from Financing (Quarterly) | 813.17M |
| Free Cash Flow Per Share (Quarterly) | 1.010 |
| Free Cash Flow to Equity (Quarterly) | -603.66M |
| Free Cash Flow to Firm (Quarterly) | 210.91M |
| Free Cash Flow Yield | 7.43% |